NCT05397600 Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients Status COMPLETED Phase PHASE3
NCT05394324 A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products Status COMPLETED Phase N/A
NCT05389267 Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05344651 Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium Status RECRUITING Phase NA
NCT05319470 Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives Status COMPLETED Phase N/A
NCT05299281 Micropulse Transscleral Diode Laser Cyclophotocoagulation (MP-TSCPC) as a Treatment Modality for Glaucoma Patients Status COMPLETED Phase NA
NCT05273385 Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma Status TERMINATED Phase NA
NCT05264818 Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma Status RECRUITING Phase N/A
NCT05251792 Macular Pigment Optical Density in Primary Angle-closure Disease Status UNKNOWN Phase N/A